Methotrexate inhibits SARS‐CoV‐2 virus replication “in vitro”메토트렉세이트는 "시험관 내" SARS-CoV-2 바이러스 복제를 억제합니다Short Communication Published on 2020-09-282022-09-10 Journal: Journal of medical virology [Category] SARS, 신약개발, 치료제, [키워드] Antiviral Antiviral treatment approach block caused Complication complications Concentration COVID‐19 COVID‐19 death deaths Depression diffusion Drug repurposing drug treatment drug treatments effective global public health Highlights identify Infection inhibit inhibiting inhibitor methotrexate pandemic pathway Patient Prevent provide purine purine biosynthesis inhibition Replication respiratory ribonucleotide ribonucleotides SARS‐CoV‐2 SARS‐CoV‐2 virus Spread Stage Symptom syndrome the disease therapy Vaccine Viral Viral protein viral replication Viral RNA viral RNA synthesis virus Wuhan Wuhan, China zoonotic [DOI] 10.1002/jmv.26512 PMC 바로가기 [Article Type] Short Communication
C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysisResearch Published on 2020-09-092022-10-29 Journal: Translational Medicine Communications [Category] COVID-19, [키워드] activated addition can be used CCL11 CCL4 CCL8 CCR5 cells Chemokine receptor chemotactic coronavirus disease COVID-19 COVID-19 infection Critical disease drug Effects explain Factors HCQ highlight identify immune cell population immune cell recruitment in silico analysis in silico Approach increased risk interfere lack lung tissue Lungs mechanism methotrexate Mild molecular molecular mechanisms monotherapy natural killer pathway Patient patient group potential therapy RA synovium receptor reduced Research rheumatic disease rheumatoid arthritis significantly susceptible therapy transcriptomic profile treat upregulated upregulation [DOI] 10.1186/s41231-020-00066-x PMC 바로가기 [Article Type] Research
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trialRheumatoid Arthritis Published on 2020-09-012024-09-04 Journal: Annals of the rheumatic diseases [Category] 대상포진, [키워드] Arthritis Health care methotrexate outcome assessment Rheumatoid tumor necrosis factor inhibitors [DOI] 10.1136/annrheumdis-2020-217485 PMC 바로가기 [Article Type] Rheumatoid Arthritis
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients seriesOriginal Article Published on 2020-08-272022-10-31 Journal: Clinical Rheumatology [Category] COVID-19, MERS, SARS, [키워드] absence Arthritis Autoimmune Autoimmune systemic diseases comparison condition conditions Connective tissue diseases COVID-19 develop Diagnosis disease disease-modifying anti-rheumatic drug Disease-modifying anti-rheumatic drugs General population generally mild geographical area impairment Infection Inflammatory Interaction investigated Italian Italian patient manifestation Manifestations measure medium methotrexate multicenter overlapping pandemic Patient Point positive Prevalence protective role Region Result Rheumatic diseases SARS-CoV-2 significantly higher stimulate susceptibility Swab test symptomatic COVID-19 Symptoms systemic disease systemic diseases tissue Treatment Tuscany Virological virus [DOI] 10.1007/s10067-020-05334-7 PMC 바로가기 [Article Type] Original Article
Management Issues in Myasthenia Gravis Patients Living With HIV: A Case Series and Literature Reviewarticle Published on 2020-08-212024-09-02 Journal: Frontiers in Neurology [Category] 대상포진, [키워드] Autoimmune HIV immune restoration immunosuppressive therapy methotrexate myasthenia gravis rituximab [DOI] 10.3389/fneur.2020.00775 PMC 바로가기 [Article Type] article
Beyond Methotrexate and Biologics in RA – Efficacy of JAK Inhibitors and their Place in the Current Treatment ArmamentariumReview Published on 2020-06-112024-09-02 Journal: Mediterranean Journal of Rheumatology [Category] 대상포진, [키워드] biologics jak inhibitors methotrexate rheumatoid arthritis Treatment [DOI] 10.31138/mjr.31.1.120 PMC 바로가기 [Article Type] Review
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 48 hour Admission allergic reaction anticipated application AST/ALT Bacterial infection Bacterial infections blinded block Breast feeding clinical clinical trial Combination concealed conducted Contraception Control COVID-19 COVID-19 patient criteria defined dependent on Desirable diagnostic Diaphragm dissemination dose double blind ECMO Efficacy Efficacy and safety element Endpoint evaluate extracorporeal membrane oxygenation failure female Germany Hospital stay Hydroxychloroquine IL-6-Rezeptor blockade Immunosuppression immunosuppressive therapy IMV independent Inflammation ingredient Injury Inpatient intensive care units interfere Invasive mechanical ventilation investigator investigators less life lung failure mechanical ventilation methotrexate NaCl NIV non-invasive ventilation number objective outcome parallel group parameters participant Participation Pathogenesis Patient patients PCT performed placebo-controlled trial Pneumonia polymerase chain positive Prednisolone produced progression proof protocol Pulmonary function pulmonary inflammation Quality of life randomisation randomised randomised controlled trial recruited reduce Registered respiratory Safe Sample size SARS-CoV-2 SARS-CoV2 SARS-CoV2 infection SAS severe COVID-19 Severe COVID-19 pneumonia Simultaneous single dose status stratified Study protocol sulfasalazine System the patient therapy Tocilizumab Treatment Trial trials Tuberculosis ULN unit Ventilation ventilator ventilator free day ventilator free days VFD Viral hepatitis website [DOI] 10.1186/s13063-020-04447-3 PMC 바로가기 [Article Type] Letter
Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based ApproachReview Published on 2020-05-222022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] addition adjusted affecting approach Bladder cancer Care Chemotherapy city Clinical practice Community coronavirus disease COVID-19 COVID-19 cases curative intent death decrease disease donning Doxorubicin facemask healthcare facility Hope individual International Local managing manuscript methotrexate Novel coronavirus outcome pandemic patients Physicians Precaution Prevalence receiving risk Surveillance team-based medicine the patient therapy Treatment unique urothelial carcinoma vinblastine widespread with COVID-19 [DOI] 10.3390/jcm9051574 PMC 바로가기 [Article Type] Review
COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statementReview Article Published on 2020-05-032023-06-16 Journal: The Australasian journal of dermatology [Category] MERS, SARS, [키워드] biologic agents biologics Ciclosporin COVID‐19 dermatolology immunomodulators Janus kinase inhibitors methotrexate systemic steroids [DOI] 10.1111/ajd.13313 PMC 바로가기 [Article Type] Review Article
Traditional Chinese medicine Biqi capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trialResearch Published on 2020-04-232024-09-02 Journal: Chinese Medicine [Category] 대상포진, [키워드] Biqi capsule clinical trial complementary therapy leflunomide metabolomics methotrexate rheumatoid arthritis Th2 inflammation [DOI] 10.1186/s13020-020-00319-9 PMC 바로가기 [Article Type] Research